Choosing optimal antiretroviral therapies in 2008.
Laurence
Jeffrey
J
Laboratory for AIDS Virus Research, Weill Cornell Medical College, New York, USA.
D019380:Anti-HIV Agents / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy* / Q000821:virology; D015497:HIV-1 / Q000187:drug effects / Q000502:physiology; D006509:Hepatitis B / Q000150:complications / Q000188:drug therapy / Q000821:virology; D006515:Hepatitis B virus / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D012367:RNA, Viral / Q000097:blood; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use
D019380:Anti-HIV Agents; D012367:RNA, Viral; D018894:Reverse Transcriptase Inhibitors